| 12.08 08:53 | dpa-AFX: *STIFEL RAISES SMITH & NEPHEW PRICE TARGET TO 1145 (1075) PENCE - 'HOLD' |
| 07.08 10:12 | dpa-AFX: *UBS RAISES SMITH & NEPHEW PRICE TARGET TO 1350 (1200) PENCE - 'BUY' |
| 07.08 10:12 | dpa-AFX: *UBS HEBT ZIEL FÜR SMITH & NEPHEW AUF 1350 (1200) PENCE - 'BUY' |
| 02.08 06:54 | dpa-AFX: *BARCLAYS RAISES SMITH & NEPHEW TARGET TO 1205 (1190) PENCE - 'EQUAL WEIGHT' |
| 02.08 06:13 | dpa-AFX: *JPMORGAN CUTS SMITH & NEPHEW PRICE TARGET TO 1248 (1381) PENCE - 'OVERWEIGHT' |
| 01.08 16:44 | dpa-AFX: *JEFFERIES RAISES SMITH & NEPHEW PRICE TARGET TO 1400 (1250) PENCE - 'BUY' |
| 01.08 10:25 | dpa-AFX: Smith & Nephew H1 Pretax Profit Rises; Revenue Up 4.3% On Underlying Basis |
| 01.08 09:09 | dpa-AFX: *SMITH+NEPHEW H1 EPS 24.5C VS 19.7C LAST YEAR |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW H1 NET INCOME $214 MLN VS. $172 MLN LAST YEAR |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW H1 PRE-TAX INCOME $253 MLN VS. $211 MLN LAST YEAR |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW EXPECTS FY24 REVENUE GROWTH OF 5.0% TO 6.0% |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW H1 ADJ. EPS 37.6C VS. 34.9C LAST YEAR |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW H1 EPS 24.5C VS 19.7C LAST YEAR |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW H1 TRADING PROFIT $471 MLN VS. $417 MLN LAST YEAR |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW H1 OPERATING PROFIT $328 MLN VS. $275 MLN LAST YEAR |
| 01.08 08:10 | dpa-AFX: *SMITH & NEPHEW H1 REVENUE $2.827 BLN VS. $2.734 BLN LAST YEAR |
| 30.07 14:00 | dpa-AFX: GNW-Adhoc: Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers |
| 24.07 08:14 | dpa-AFX: *DEUTSCHE BANK RESEARCH STARTS SMITH & NEPHEW WITH 'BUY' - PRICE TARGET 1350 PENCE |
| 24.07 08:14 | dpa-AFX: *DEUTSCHE BANK RESEARCH STARTET SMITH & NEPHEW MIT 'BUY' - ZIEL 1350 PENCE |
| 16.07 15:07 | dpa-AFX: Smith+Nephew Announces FDA Clearance For New CATALYSTEM Primary Hip System |
|
|
